Discordance between dipyridamole stress Tc-99m sestamibi SPECT and coronary angiography in patients with Kawasaki disease

被引:6
|
作者
Fu, YC
Kao, CH
Hwang, B
Jan, SL
Chi, CS
机构
[1] Taichung Vet Gen Hosp, Dept Pediat, Taichung, Taiwan
[2] Taichung Vet Gen Hosp, Dept Nucl Med, Taichung, Taiwan
[3] Natl Yang Ming Univ, Taipei 112, Taiwan
[4] Taipei Vet Gen Hosp, Taipei, Taiwan
关键词
coronary angiography; dipyridamole; Kawasaki disease; sestamibi; single photon emission computed tomography;
D O I
10.1067/mnc.2002.118238
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Kawasaki disease is an acute vasculitis syndrome of unknown etiology that mainly affects the coronary arteries. The purpose of this study was to assess the agreement between dipyridamole stress technetium 99m sestamibi single photon emission computed tomography (SPECT) and coronary angiography in these patients. Methods and Results. Forty-one consecutive patients (29 boys and 12 girls) who underwent coronary angiography were studied prospectively. Their ages at onset of the disease ranged from 2 months to 4.8 years (mean+/-SD, 1.9+/-1.3 years). Their ages at the time of the study ranged from 8 months to 15.3 years (6.2+/-4.4 years). The duration between symptom onset and the study ranged from 2 months to 12 years (4.3+/-4.0 years). All patients underwent dipyridamole stress Tc-99m sestamibi SPECT within 1 month of their angiographic studies. They were divided into 3 groups according to coronary angiography findings. Group A consisted of 2 patients (I boy and 1 girl, aged 10.3 and 1.9 years, respectively) with coronary stenoses who also had aneurysms. Group B consisted of 10 patients (8 boys and 2 girls, aged 0.7-15.3 years [mean, 3.8 years]) with coronary aneurysms. Group C consisted of 29 patients (20 boys and 9 girls, aged 1.2-13.8 years [mean, 7 years]) with normal coronary angiograms. Two patients in group A (100%), 3 of 10 patients in group B (30%), and 19 of 29 patients in group C (65.5%) had myocardial perfusion defects. There was poor agreement between Tc-99m sestamibi SPECT and coronary angiography for detecting coronary stenoses (kappa=0.07; P=.222) and aneurysms (kappa=-0.184; P=.158). Conclusion. Significant discordance exists between Tc-99m sestamibi SPECT and coronary angiography in patients with Kawasaki disease.
引用
收藏
页码:41 / 46
页数:6
相关论文
共 50 条
  • [1] Discordance between dipyridamole stress Tc-99m sestamibi SPECT and coronary angiography in patients with Kawasaki disease
    Yun-Ching Fu
    Chia-Hung Kao
    Betau Hwang
    Sheng-Ling Jan
    Ching-Shiang Chi
    Journal of Nuclear Cardiology, 2002, 9 : 41 - 46
  • [2] (99)TC(M)-SESTAMIBI SPECT WITH COMBINED DIPYRIDAMOLE AND EXERCISE STRESS IN CORONARY-ARTERY DISEASE
    CRAMER, MJM
    VERZIJLBERGEN, JF
    NIEMEYER, MG
    VANDERWALL, EE
    ZWINDERMAN, AH
    ASCOOP, CAPL
    PAUWELS, EKJ
    NUCLEAR MEDICINE COMMUNICATIONS, 1994, 15 (07) : 554 - 559
  • [3] Gated Tc-99m sestamibi SPECT versus stress-rest SPECT in detecting coronary artery disease - Correlation with coronary angiography in patients without myocardial infarction
    Guerra, UP
    Giacomuzzi, F
    Di Gregorio, F
    Bax, JJ
    Slavich, GA
    Fioretti, PM
    CLINICAL NUCLEAR MEDICINE, 1999, 24 (12) : 921 - 926
  • [4] Tc-99m sestamibi cardiac SPECT imaging during coronary artery occlusion in humans: Comparison with dipyridamole stress studies
    BorgesNeto, S
    Watson, JE
    Miller, MJ
    RADIOLOGY, 1996, 198 (03) : 751 - 754
  • [5] Discordance between dipyridamole stress technetium-99m tetrofosmin single photon emission computed tomography and coronary angiography in patients with Kawasaki disease
    Yun-Ching Fu
    Yu-Chien Shiau
    Shih-Chuan Tsai
    Albert Kao
    Betau Hwang
    Ching-Shiang Chi
    The International Journal of Cardiovascular Imaging, 2002, 18 : 357 - 362
  • [6] Discordance between dipyridamole stress technetium-99m tetrofosmin single photon emission computed tomography and coronary angiography in patients with Kawasaki disease
    Fu, YC
    Shiau, YC
    Tsai, SC
    Kao, A
    Hwang, BT
    Chi, CS
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2002, 18 (05): : 357 - 362
  • [7] DIPYRIDAMOLE TC-99M SESTAMIBI SPECT MYOCARDIAL PERFUSION IMAGING - PROGNOSTIC IMPLICATIONS
    HERMAN, SD
    SANTOSOCAMPO, CD
    MCCLELLAN, JR
    CLOUTIER, DJ
    GARBER, CE
    BARON, JI
    TRAVIN, MI
    HELLER, GV
    JOURNAL OF NUCLEAR MEDICINE, 1993, 34 (05) : P85 - P85
  • [8] PROGNOSIS IN 484 CONSECUTIVE PATIENTS FOLLOWING INTRAVENOUS DIPYRIDAMOLE TC-99M SESTAMIBI SPECT IMAGING
    HERMAN, SD
    GARBER, CE
    TRAVIN, MI
    MCCLELLAN, JR
    CLOUTIER, DJ
    BARON, JI
    RAMA, PR
    HELLER, SV
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, : A63 - A63
  • [9] Is dobutamine superior to dipyridamole in evaluating the severity and reversibility of defects using Tc-99m sestamibi SPECT imaging in patients with coronary artery disease?
    deGroot, MC
    Ahlberg, AW
    Marini, D
    McGill, CC
    Cyr, GM
    Mann, A
    Heller, GV
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 473A - 474A
  • [10] Comparison between Tc-99m-sestamibi and Tc-99m-tetrofosmin SPECT imaging with dipyridamole in detection of coronary artery disease.
    Taillefer, R
    Bernier, H
    Lambert, R
    Turpin, S
    Léveillé, J
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 17P - 17P